Ashizuka S - Search Results

1

Adrenomedullin Therapy in Patients with Refractory Ulcerative Colitis: A Case Series.

Ashizuka S, Inatsu H, Kita T, Kitamura K. Ashizuka S, et al. Dig Dis Sci. 2016 Mar;61(3):872-80. doi: 10.1007/s10620-015-3917-0. Epub 2015 Oct 15. Dig Dis Sci. 2016. PMID: 26470867 Free PMC article.

2

Effect of adrenomedullin administration on acetic acid-induced colitis in rats.

Ashizuka S, Ishikawa N, Kato J, Yamaga J, Inatsu H, Eto T, Kitamura K. Ashizuka S, et al. Peptides. 2005 Dec;26(12):2610-5. doi: 10.1016/j.peptides.2005.05.007. Epub 2005 Jun 23. Peptides. 2005. PMID: 15978699

3

Leukocytapheresis for ulcerative colitis: a comparative study of anticoagulant (nafamostat mesilate vs. dalteparin sodium) for reducing clinical complications.

Ashizuka S, Nishiura R, Ishikawa N, Yamaga J, Inatsu H, Fujimoto S, Eto T. Ashizuka S, et al. Ther Apher Dial. 2006 Feb;10(1):54-8. doi: 10.1111/j.1744-9987.2006.00309.x. Ther Apher Dial. 2006. PMID: 16556137

4

Adrenomedullin treatment reduces intestinal inflammation and maintains epithelial barrier function in mice administered dextran sulphate sodium.

Ashizuka S, Inagaki-Ohara K, Kuwasako K, Kato J, Inatsu H, Kitamura K. Ashizuka S, et al. Microbiol Immunol. 2009 Oct;53(10):573-81. doi: 10.1111/j.1348-0421.2009.00159.x. Microbiol Immunol. 2009. PMID: 19780971 Free article.

5

Adrenomedullin: a novel therapy for intractable ulcerative colitis.

Ashizuka S, Kita T, Inatsu H, Kitamura K. Ashizuka S, et al. Inflamm Bowel Dis. 2013 Feb;19(2):E26-7. doi: 10.1002/ibd.22891. Inflamm Bowel Dis. 2013. PMID: 22294498 No abstract available.

6

Effectiveness of concomitant enteral nutrition therapy and infliximab for maintenance treatment of Crohn's disease in adults.

Hirai F, Ishihara H, Yada S, Esaki M, Ohwan T, Nozaki R, Ashizuka S, Inatsu H, Ohi H, Aoyagi K, Mizuta Y, Matsumoto T, Matsui T. Hirai F, et al. Among authors: ashizuka s. Dig Dis Sci. 2013 May;58(5):1329-34. doi: 10.1007/s10620-012-2374-2. Epub 2012 Aug 29. Dig Dis Sci. 2013. PMID: 22926500 Free PMC article.

7

Adrenomedullin as a potential therapeutic agent for inflammatory bowel disease.

Ashizuka S, Inatsu H, Inagaki-Ohara K, Kita T, Kitamura K. Ashizuka S, et al. Curr Protein Pept Sci. 2013 Jun;14(4):246-55. doi: 10.2174/13892037113149990044. Curr Protein Pept Sci. 2013. PMID: 23745693 Review.

8

Effect of a concomitant elemental diet with maintenance anti-tumor necrosis factor-α antibody therapy in patients with Crohn's disease: A multicenter, prospective cohort study.

Hirai F, Ishida T, Takeshima F, Yamamoto S, Yoshikawa I, Ashizuka S, Inatsu H, Mitsuyama K, Sou S, Iwakiri R, Nozaki R, Ohi H, Esaki M, Iida M, Matsui T; Additional Power of Elemental Diet on Maintenance Biologics Therapy in Crohn's Disease (ADORE) Study Group. Hirai F, et al. Among authors: ashizuka s. J Gastroenterol Hepatol. 2019 Jan;34(1):132-139. doi: 10.1111/jgh.14361. Epub 2018 Jul 16. J Gastroenterol Hepatol. 2019. PMID: 29935082 Free PMC article.

9

Subcutaneously administered adrenomedullin exerts a potent therapeutic effect in a murine model of ulcerative colitis.

Kinoshita Y, Arita S, Murazoe H, Kitamura K, Ashizuka S, Inagaki-Ohara K. Kinoshita Y, et al. Among authors: ashizuka s. Hum Cell. 2019 Jan;32(1):12-21. doi: 10.1007/s13577-018-0219-9. Epub 2018 Oct 10. Hum Cell. 2019. PMID: 30306504

10

Adrenomedullin: A Novel Therapy for Intractable Crohn's Disease with a Loss of Response to Infliximab.

Ashizuka S, Kuroishi N, Nakashima K, Inatsu H, Kita T, Kitamura K. Ashizuka S, et al. Intern Med. 2019 Jun 1;58(11):1573-1576. doi: 10.2169/internalmedicine.1791-18. Epub 2019 Feb 1. Intern Med. 2019. PMID: 30713309 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page